SCHEMBL4690922

SCHEMBL4690922

O=C1COc2ccc3c(c2N1)C(=O)CC3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 3/20 0.41
MMP12 P39900 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
PARP1 P09874 3/20 0.38
ALDH1A1 P00352 4/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MAPT P10636 3/20 0.35
GRM5 P41594 1/20 0.34
PKM P14618 2/20 0.34
GAA P10253 2/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
NPC1 O15118 1/20 0.33
MAPK13 O15264 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4685547 0.78 MTNR1A (0.38) NR3C2MMP12MTNR1AMTNR1BPARP1
SCHEMBL4685551 0.78 MTNR1A (0.38) NR3C2MMP12MTNR1AMTNR1BPARP1
SCHEMBL30771064 0.69 NR3C2 (0.39) NR3C2MMP12MTNR1AMTNR1BPARP1
SCHEMBL17348473 0.68 NR3C2 (0.57) NR3C2MMP12MTNR1AMTNR1BPARP1
SCHEMBL4095480 0.68 MMP12 (0.44) NR3C2MMP12PARP1ALDH1A1KMT2A
SCHEMBL6432532 0.67 NR3C2 (0.56) NR3C2MMP12MTNR1AMTNR1BPARP1
SCHEMBL15053068 0.67 DRD2 (0.43) NR3C2MMP12PARP1ALDH1A1KMT2A
SCHEMBL338965 0.66 MTNR1A (0.44) MTNR1AMTNR1B
SCHEMBL23001518 0.66 MMP12 (0.49) NR3C2MMP12MTNR1AMTNR1BPARP1
SCHEMBL3489583 0.66 NR3C2 (0.55) NR3C2MMP12MTNR1AMTNR1BPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885210-B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use TAKEDA PHARMACEUTICAL (JP) 2008-06-18 EP disclosed
EP-1550655-A1 Bicyclic intermediates Takeda Pharmaceutical Company Limited (JP) 2005-07-06 EP disclosed
EP-0885210-B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-06-12 EP disclosed
EP-1199304-A1 Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders Takeda Chemical Industries, Ltd. (JP) 2002-04-24 EP disclosed
US-6218429-B1 TREATING MELATONIN RELATED DISORDERS (E.G. CIRCARDIAN RHYTHMS, SLEEP-AWAKE CYCLES, TIME ZONE CHANGES, SLEEP DISORDERS) TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-04-17 US disclosed
US-6034239-A BINDIG TO MELATONIN RECEPTORS; SLEEP DISORDERS; GLANDULAR DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-03-07 US disclosed